Résumé
Des études ont montré que le traitement par chimiothérapie adjuvante du cancer du sein peut être associé à des déficits cognitifs légers. Ces troubles ont un impact négatif sur la qualité de vie des patientes, et la compréhension de leur origine et des processus altérés est actuellement un des enjeux importants de ce nouveau thème de recherche. Peu d’études ont été réalisées auprès de patientes âgées, alors que l’âge est le facteur de risque le plus important pour ce cancer. Cet article propose une synthèse de la littérature et discute de l’incidence de tels troubles chez les patients âgés.
Abstract
Understanding the neuropsychological consequences of chemotherapy is a major challenge. Studies have shown that treatment with adjuvant chemotherapy for breast cancer may be associated with mild cognitive deficits. These disorders have a negative impact on the quality of life of patients. Few studies have been conducted with elderly patients, although the age factor is the biggest risk for this cancer. This article offers an overview of the literature and discusses the impact of such impairments in the elderly.
Article PDF
Avoid common mistakes on your manuscript.
Références
Ahles TA, Saykin AJ, Furstenberg CT, et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in longterm survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493
Anderson-Hanley C, Sherman ML, Riggs R, et al (2003) Neuropsychological effects of treatments for adults with cancer: a metaanalysis and review of the literature. J Int Neuropsychol Soc 9:967–982
Bender CM, Sereika SM, Berga SL, et al (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430
Brezden CB, Phillips KA, Abdolell M, et al (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701
Broadbent DE, Cooper PF, FitzGerald P, Parkes KR (1982) The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol 21(Pt 1):1–16
Castellon SA, Ganz PA, Bower JE, et al (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955–969
de Ruiter MB, Reneman L, Boogerd W, et al (2010) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp (Epub ahead of print)
Dolbeault S, Szporn A, Holland JC (1999) Psycho-oncology: where have we been? Where are we going? Eur J Cancer 35:1554–1558
Downie FP, Mar-Fan HG, Houede-Tchen N, et al (2006) Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology 15:921–930
Dubois M, Roy V, Villier V, et al (2010) Age-related cognitive function and cerebral plasticity in miceafter chemotherapy: Important role of drug adjuvants. J Clin Oncol (Meeting Abstracts) 28
Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA (2007) Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866–3870
Ganz PA, Desmond KA, Leedham B, et al (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49
Hermelink K, Untch M, Lux MP, et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913
Hess LM, Insel KC (2007) Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum 34:981–994
Hurria A, Goldfarb S, Rosen C, et al (2006) Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective. Breast Cancer Res Treat 98:343–348
Hurria A, Rosen C, Hudis C, et al (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54: 925–931
Iconomou G, Mega V, Koutras A, et al (2004) Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101:404–411
Inagaki M, Yoshikawa E, Matsuoka Y, et al (2007) Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109:146–156
Jansen CE, Miaskowski C, Dodd M, et al (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104:2222–2233
Jenkins V, Shilling V, Deutsch G, et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834
Johnson T, Monk T, Rasmussen LS, et al (2002) Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology 96:1351–1357
McCracken LM, Iverson GL (2001) Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 21:392–396
McNair DM, Kahn RJ (1984) Self-assessment of cognitive deficits. In: Crook T, Ferris S, Bartus R (eds) Assessment in geriatric psychopharmacology. Mark Powley, New Canaan, CT, pp 137–143
Mehnert A, Scherwath A, Schirmer L, et al (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus highdose chemotherapy. Patient Educ Couns 66:108–118
Meyers CA, Albitar M, Estey E (2005) Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104:788–793
Minisini AM, De Faccio S, Ermacora P, et al (2008) Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study. Crit Rev Oncol Hematol 67:71–79
Morel N, Eustache F, Lange M, et al (2010) L’impact du cancer et de ses traitements sur les fonctions cognitives: l’exemple du cancer du sein. Revue de neuropsychologie 2(3):250–254
Quesnel C, Savard J, Ivers H (2009) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116:113–123
Reichenberg A, Yirmiya R, Schuld A, et al (2001) Cytokineassociated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452
Reid-Arndt SA, Hsieh C, Perry MC (2010) Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology 19:535–544
Schagen SB, Muller MJ, Boogerd W, et al (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387–1397
Schagen SB, van Dam FS, Muller MJ, et al (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650
Seigers R, Schagen SB, Coppens CM, et al (2009) Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res 201:279–284
Shilling V, Jenkins V, Morris R, et al (2005) The effects of adjuvant chemotherapy on cognition in women with breast cancer — preliminary results of an observational longitudinal study. Breast 14:142–150
Shilling V, Jenkins V, Trapala IS (2006) The (mis)classification of chemo-fog — methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 95:125–129
Silverman DH, Dy CJ, Castellon SA, et al (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat 103:303–311
Stern Y (2003) The concept of cognitive reserve: a catalyst for research. J Clin Exp Neuropsychol 25:589–593
Tager FA, McKinley PS, Schnabel FR, et al (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123:25–34
Tchen N, Juffs HG, Downie FP, et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183
van Dam FS, Schagen SB, Muller MJ, et al (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218
Vandenbossche S, Fery P, Razavi D (2009) Cognitive impairments and breast cancer: a critical review of the literature. Bull Cancer 96:239–248
Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455–2463
Vardy J, Wefel JS, Ahles T, et al (2008) Cancer and cancertherapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629
Wagner L, Sweet J, Butt Z, et al (2009) Measuring patient selfreported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7:W32–W39
Wagner LI, Cella D (2004) Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91:822–828
Wefel JS, Lenzi R, Theriault R, et al (2004) ’Chemobrain’ in breast carcinoma?: a prologue. Cancer 101:466–475
Wefel JS, Lenzi R, Theriault RL, et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299
Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356
Wieneke M, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61–66
Yamada TH, Denburg NL, Beglinger LJ, Schultz SK (2010) Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci 22:48–54
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Lange, M., Giffard, B., Eustache, F. et al. Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature. Psycho Oncologie 5, 3–10 (2011). https://doi.org/10.1007/s11839-010-0303-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11839-010-0303-1